Comparative Efficacy and Safety of Empagliflozin with Other Antidiabetic Drugs for the Third Line Treatment of Type 2 Diabetes Mellitus
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.630
https://www.valueinhealthjournal.com/article/S1098-3015(14)02560-1/fulltext
Section Title :
Disease-Specific Studies
Section Order :
58
First Page :
A333
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02560-1&doi=10.1016/j.jval.2014.08.630